Phase Ib Dose-Finding Study of Axitinib Plus Pembrolizumab in Treatment-NaÃ¯ve PatientsWith Advanced Renal Cell Carcinoma

Editor

9 years ago

Toni Choueiri, MD Dana-Farber Cancer Institute presents “Phase Ib Dose-Finding Study of Axitinib Plus Pembrolizumab in Treatment-NaÃ¯ve PatientsWith Advanced Renal Cell Carcinoma” at the 14th International Kidney Cancer Symposium.